11C-UCB-J | m-entrepreneurship.com

Product Name :
11C-UCB-J

Search keywords :
UCB-J

drugId :
null

Target Vo:
Synaptic vesicle glycoprotein 2A

Target Vo Short Name :
SV2A

Moa_Name:
Synaptic vesicle glycoprotein 2A modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ucb Sa

Active Company_Name :
University Of Wisconsin-Madison

Active Indication_Name:
Alzheimer Disease

In Active Indication_Name:
Depressive Disorder, Major

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
COX2 Mouse mAb Autophagy
Clathrin heavy chain Rabbit mAb In Vivo
CD3G Antibody: CD3G Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to CD3G. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts